En español

Menu

Publications

Quick Links

COVID-19 is an emerging, rapidly evolving situation.


Get the latest information from CDC (Coronavirus.gov) | NIH Resources | NIDA Resources

NIDA Notes Articles: Methamphetamine

NIDA Notes Category Graphic

Part 2: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

February 2020
Researchers move their monoclonal antibody (mAb) into clinical trials to see if it can be an effective treatment for methamphetamine use.

NIDA Notes Category Graphic

Part 1: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

January 2020
Researchers have created a monoclonal antibody (mAb) that is intended to interact with methamphetamine and decrease its ability to enter the brain.

NIDA Notes Category Graphic

Nerve-Cell Growth During Abstinence From Methamphetamine May Promote Reinstatement of Drug Use in Rats

November 2019
Neurogenesis that occurs during abstinence from methamphetamine in a brain region related to memory and learning may promote relapse-like behavior.

NIDA Notes Category Graphic

Rats Prefer Social Interaction to Heroin or Methamphetamine

August 2019
This study showed that rats will forgo heroin and methamphetamine in favor of spending time with another rat. It also highlights the importance of incorporating voluntary choice between drugs and social rewards in drug addiction research.

NIDA Notes Category Graphic

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 4

May 2019
Dr. Linda Dwoskin wins a NIDA grant to continue her team's work to find a medication to treat methamphetamine addiction—but there's a string attached.

NIDA Notes Category Graphic

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 3

May 2018
Dr. Linda Dwoskin feels just one small step away from success in her effort to develop the first ever medication to treat methamphetamine addiction.

NIDA Notes Category Graphic

Narrative of Discovery: In Search of a Medication To Treat Methamphetamine Addiction, Part 2

April 2016
When lobeline turned out not to be the answer, it became a starting point. Dr. Linda Dwoskin and her team set out to transform the molecule into something more effective and with fewer side effects.

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics